methylene blue has been researched along with Cranial Nerve II Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, EYP; Fung, JCL | 1 |
1 other study(ies) available for methylene blue and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Methylene blue promotes survival and GAP-43 expression of retinal ganglion cells after optic nerve transection.
Topics: Animals; Axons; Cell Survival; Cricetinae; Disease Models, Animal; Female; GAP-43 Protein; Intravitreal Injections; Methylene Blue; Nerve Regeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Retinal Ganglion Cells; Time Factors | 2020 |